Login / Signup

The effects of selected biologics and a small molecule on Health-Related Quality of Life in adult plaque psoriasis patients: A systematic review and meta-analysis.

Anna Karpińska-MireckaJoanna BartosińskaDorota Maria Krasowska
Published in: PloS one (2020)
Infliximab, adalimumab, ixekizumab, secukinumab and tofacitinib in adult plaque psoriatic patients improved HRQOL measured by the DLQI. The patients with lower quality of life before treatment obtained better results.
Keyphrases